Robot-Assisted Retroperitoneal Lymphadenectomy in Testicular Cancer Treatment: A Systematic Review.

Published

Journal Article (Review)

INTRODUCTION: Retroperitoneal lymph node dissection (RPLND) in testicular cancer is a documented treatment along with active surveillance and chemotherapy. This study aims to summarize the current evidence on the use of Robot-assisted RPLND (RARPLND) in comparison with the laparoscopic and open approach. MATERIALS AND METHODS: A search was conducted in the existing literature focusing on reports with outcomes of RARPLND for stage I-IIB testicular tumor. RESULTS: Eleven studies complied with the inclusion criteria, including 116 patients. The average follow-up of 21.2 months showed no retroperitoneal recurrence. The median lymph node yield was 22.3 and the overall positive rate was 26%. Complications were encountered in 8% of the patients. The robotic approach showed similar results to the laparoscopic approach and outperformed the open procedure in perioperative parameters. CONCLUSIONS: Relapse-free survival, nodal yield, and complication rates during RARPLND for clinical stage I-IIB are acceptable. Further studies are required to establish these findings and determine benefit from the use of robotic approach.

Full Text

Duke Authors

Cited Authors

  • Tselos, A; Moris, D; Tsilimigras, DI; Fragkiadis, E; Mpaili, E; Sakarellos, P; Vailas, M; Shah, KN; Papalampros, A

Published Date

  • June 2018

Published In

Volume / Issue

  • 28 / 6

Start / End Page

  • 682 - 689

PubMed ID

  • 29474141

Pubmed Central ID

  • 29474141

Electronic International Standard Serial Number (EISSN)

  • 1557-9034

Digital Object Identifier (DOI)

  • 10.1089/lap.2017.0672

Language

  • eng

Conference Location

  • United States